text:
Organic Harmony Soup Blend
The best mix everEmily, Barberton, OH
Lovely bunch of beans here, guys! A Hank of ham, a couple of hours, and we had a little bowl of heaven!Barb, Springfield, MO
I keep buying this repeatedly, which is an excellent recommendation!Ty, Page, AZ
Mixed these with some organic quinoa and curry, YUM. Top notch quality here.melinda, CALERA, AL
Organic hard red winter wheat,organic pearled barley, organic pinto beans,organic red kidney beans, organic split green peas, organic red rice, organic black beans, organic navy beans, organic safflower oil. Packaged in the same facility as peanuts, tree nuts, wheat, soy, and milk products.
Serving size 35g (~1.2 oz.)
|Amount per serving|
|Calories from Fat|
Store in a cool dry place for up to 1 year. It is ok to refrigerate.
Country of origin: United States


text:
Can you complete the 100 levels?
General knowledge, skill, reflexes, memory ... All your skills will be put to the test!
Each lost level takes you to the previous level, but it will have changed in the meantime!
Fortunately, little games are there to relax... or make you even crazier :)
Minor bug fix
Ratings and Reviews
I like it
I love the different challenges in this game but I just feel that some of the tasks need to be clearer.
Just rating for jokers...
I haven't even been playing for 10 minutes, not enough time to play the full game, and I'm asked to give a review in order to get more help in the game. So, here it is. I'll change this once I actually play the whole game. Maybe.
Amazing but stressful
Its so much fun but its sooooooo stressful 😫👌🏻
- Kek Zanorg
- 37.2 MB
Requires iOS 6.0 or later. Compatible with iPhone, iPad, and iPod touch.
- Age Rating
- Rated 4+
- © 2015 zanorg
- In-App Purchases
- 15 Jokers Pack $1.99
- 5 Jokers pack $0.99
Challenge friends and check leaderboards and achievements.
With Family Sharing set up, up to six family members can use this app.

domain: game


Friends of WPL
The Friends of the Winona Public Library value, support, and champion the public library. The purpose of this organization is to:
- Maintain an association of persons interested in libraries
- Focus public attention on the Winona Public Library
- Stimulate the use of the library’s resources and services
- Receive and encourage gifts, endowments and bequests to the library
- Support and cooperate with the library in developing library services and facilities for the community
- Support the freedom to read as expressed in the American Library Association Bill of Rights
- Volunteer for Friends events
Fill out our online form to become a member.
The next meeting will be held on Saturday, December 3rd at 9:30 am in the Bell Art Room.
Monthly meetings are typically held on the third Saturday of each month from 9:30 – 10:30 am in the Bell Art Room of the library. Meeting minutes are posted after formal approval.
All Friends and potential Friends are welcome to attend.
Meeting Minutes & Reports
Friends Board Members
President: Blandine Berthelot (2022-2025)
Vice President: Dick Dahl (2020-2023)
Treasurer: Suzanne Johnson (2022-2025)
Secretary: Mary Farrell (2022-2025)
Membership Coordinator: Gayle Garrity (2020-2023)
Board Member: Katelyn Foerster (2022-2025)
Board Member: Sam Hanson (2022-2025)
Board Member: Ali Liffrig (2022-2023)
Board Member: Matthew Marek (2022-2025)
Board Member: Emily Tipton (2022-2025)
Library Liaison: Samantha Berhow
Winona Public Library
Attn: Friends of the Library
151 West 5th St
P.O. Box 1247
Winona, MN 55987


text:
Jan. 17, 2023
The U.S. Postal Service will dedicate the Women’s Soccer commemorative Forever stamp at the SheBelieves Cup in Orlando, FL.
The stamp ceremony is free and open to the public. News of the stamp is being shared with the hashtag #WomensSoccerStamp.
The Honorable Amber McReynolds, member, U.S. Postal Service Board of Governors
Thursday, Feb. 16, 2023, at 11 a.m. EST
618 W. Pine Street
Orlando, FL 32805
Dedication ceremony attendees are encouraged to RSVP at: usps.com/womenssoccer.
This new Forever stamp celebrates women’s soccer in the United States. From youth leagues to the elite world champion U.S. National Team, millions of girls and women throughout the country participate in the fast-paced, competitive sport.
Soccer, also known as football internationally, is the most popular sport in the world, played by hundreds of millions of players in almost every country. In the United States, women’s soccer has gained a firm foothold in sports and popular culture. From youth leagues to the elite world champion U.S. National Team, millions of girls and women across the country participate in the fast-paced, competitive sport.
The stamp artwork depicts a female soccer player in action, striking a ball with a side volley. Conjuring the aesthetic of mid-century print design, illustrator Noah MacMillan (1988-2022) used simplified shapes and bold colors to convey the high energy and fast motion of the sport. The somewhat grainy rendering lends a timeless quality to the design, evoking not just a single all-star athlete or era, but the entire legacy of women’s soccer.
Art director Antonio Alcalá designed the stamp.
Customers may purchase stamps and other philatelic products through the Postal Store at usps.com/shopstamps, by calling 844-737-7826, by mail through USA Philatelic or at Post Office locations nationwide.

domain: sports


text:
Silicon Motion Technology Corp. has introduced an enterprise-grade 16 channel PCIe 4.0 non-volatile memory express (NVMe) plus firmware turnkey solid state drive (SSD) controller designed for data centers.
The SM8266 controller features up to 16 TB with 16 NAND flash channels and supports the latest 3D TLC and QLC NAND flash technologies. The controller is based on Silicon Motion’s 6th generation NANDXtend technology that incorporates machine learning algorithms and the company’s high performance low-density parity-check (LDPC) error correction code (ECC) engine with redundant array of inexpensive disks (RAID).
Other features include end-to-end path protection that applies ECC to the SSD’s static random access memory (SRAM) and dynamic random access memory (DRAM) buffers as well as the primary NAND flash memory array. Power loss protection in the controller eliminates the risk of data loss in the event of an unexpected power outage.

domain: design


text:
Emergency Department Care of Adult Cystic Fibrosis Patients
Emergency Department Care of Adult Cystic Fibrosis Patients
Authors: Lisa Freeman Grossheim, MD, FACEP, Assistant Professor, Department of Emergency Medicine, University of Texas Medical School at Houston; and Keith S. Gates, MD, EMT-P, Resident, Department of Emergency Medicine, University of Texas Medical School at Houston.
Peer Reviewer: Charles Emerman, MD, Cleveland Clinic, MetroHealth Medical Center, Cleveland, OH.
With advances in medical science, patients with serious congenital diseases are living into adulthood. A previous issue of Emergency Medicine Reports dealt with adults with congenital heart disease. This issue deals with another group of survivors, those who have survived with cystic fibrosis. Where once patients died in infancy, patients now live into their 40s. Although many of the standard treatments for COPD apply to cystic fibrosis, there are specific differences in management, which this monograph highlights.
Sandra M. Schneider, MD, FACEP, Editor
A 19-year-old Caucasian male who was diagnosed with cystic fibrosis as a child presents to the emergency department in respiratory distress. His parents are at his bedside. The patient is thin, pale, chronically ill-appearing, and is in moderate distress with coughing and mild wheezing. His blood pressure is 110/60 mm Hg, heart rate 120, respiratory rate 48, temperature 99.5°F, and oxygen saturation 88% on 15 liters oxygen. The patient tells you that he was just discharged from the hospital last week and does not want to be readmitted or intubated. He says he is tired of being sick. His distraught parents are at his bedside and are asking you to do everything possible to help their son. What can you do? What should you do?
'The child will soon die whose forehead tastes salty when kissed," appeared in an 1857 Almanac of Children's Songs and Games from Switzerland 100 years before the sweat test was first used in the 1950s to help diagnose cystic fibrosis (CF), a disease that is characterized by abnormal salt transport, and, in previous years, death in infancy. Cystic fibrosis (CF) was first described as a disease entity in 1938.1,2
The important developments of the past few decades in cystic fibrosis care have led to the tremendous growth of the adult CF population. Cystic fibrosis has classically been defined as a pediatric disease since, at the time of discovery, it was invariably fatal in infancy, and in the 1950s median survival was 6 months. The median predicted survival was 16 years in 1970s. For patients born in the 1990s, median survival is predicted to be over 40 years.3,4 More than 36% of patients in the U.S. Cystic Fibrosis Registry are 18 years of age or older.5 Advances in medications and overall aggressive approach to the disease have led to this. Improved patient outcomes have been associated with comprehensive CF care centers and a multidisciplinary approach to patient care.1
Genetics and Epidemiology
Although there are reports dating from the 1650s of infants who likely had CF, the first report identifying the disease as a distinct clinical entity was published in 1938 by Dorothy Hansine Andersen, a pathologist at the Babies' Hospital in New York.2 She reported mucus plugging of the ducts of the pancreas in infants dying of malnutrition. She also first hypothesized that CF is a recessive disease. During the 1948 heat wave in New York, Paul di Sant'Agnese recognized that many of the infants presenting to the emergency department with heat-related illness and hyponatremic dehydration had CF. In subsequent summers, he determined that these patients had abnormally high sodium and chloride content in their sweat. In 1953, Dr. di Sant'Agnese and a colleague developed the sweat test, which measures for abnormal chloride levels in perspiration and, in 1959, standardization of the sweat test established this as the gold standard of CF diagnosis. In 1983, chloride transport was identified as the basic physiologic CF defect, accompanied by increased sodium reabsorption. In 1989, the discovery of the CF gene demonstrated the basic defect to be in a cAMP-regulated chloride channel.6,7
The CF trait results from a mutation of the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) found on chromosome 7. Most homozygotes for the disease have the classic triad of chronic pulmonary disease, malabsorption secondary to pancreatic insufficiency, and elevated concentration of sweat electrolytes. Although this disease affects multiple organ systems and varies greatly in severity and progression, most morbidity and over 90% of mortality results from chronic lung disease.3
Cystic fibrosis is the most common lethal inherited disease among Caucasians in the United States with an incidence of 1 in 2000-3000 whites affected. About 1 in 20-25 whites carry mutations of the CFTR gene. African Americans are affected at a rate of 1 in 15,000 and Asian Americans at 1 in 31,000. All together, approximately 30,000 children and adults have CF in the United States. Cystic fibrosis is diagnosed in males and females equally. For unclear reasons, males tend to have a longer life expectancy than females.1
The CFTR is located in the apical membrane of epithelium in the pulmonary airways, pancreatic duct, intestine, biliary ducts, and the sweat glands. The CFTR protein crosses the membranes and acts as a channel connecting cytoplasm to the surrounding fluid. This channel is the primary means for controlling the movement of chloride across the cell membrane. The CF phenotype is expressed when the patient inherits two copies of the defective gene that encodes the CFTR protein. The most common mutation associated with CF is the deletion of three base pairs that code for phenylalanine at position F508 in the 1480 amino acid sequence of the CFTR protein.8 Once the deletion occurs, the mutant protein does not fold properly, so it is degraded. The exocrine glands are primarily affected because a lack of CFTR gene encoded transport proteins leads to the trapping of chloride inside the cells of the glands and on the surface of the skin. Without enough functional copies of the CFTR protein in their cell membranes, epithelial cells cannot pump enough water into the mucus and other products they secrete. Therefore, the secretions are too dry, thick, and sticky and they obstruct the small airways of the lungs and ducts of various organs. The abnormally viscous mucous secretions create a nutrient rich environment that is protected from the host immune system. This leads to chronic infection, inflammation, or both and eventually leads to tissue destruction and remodeling, resulting in bronchiectasis.8 Bronchiectasis refers to localized, irreversible dilatation of bronchi. Involved bronchi are dilated, inflamed, and easily collapsible, resulting in airflow obstruction and impaired clearance of secretions.
Although diagnosis through DNA analysis is becoming a standard of care in CF, the sweat test is still the diagnostic gold standard. It is the only method of diagnosis recognized by the Cystic Fibrosis Foundation as an adequate test for definitive diagnosis of CF.5 The test involves collection of sweat by pilocarpine iontophoresis coupled with chemical determination of the chloride concentration.9,10 At least 50 mL of sweat must be collected in a 30-minute period. Using a chloride threshold of 60 mEq/L in sweat appears to distinguish nearly all adults with CF from those with other lung conditions.11 However, normal values of sweat chloride do rise with age, so higher levels may be considered normal in some patients. One to two percent of patients have clinical features consistent with CF but have normal sweat chloride levels. These patients can be diagnosed by detecting mutations in the CF gene.6
CF runs a highly varied course, ranging from death due to complications from meconium ileus in the first days of life or death from severe respiratory tract problems within the first few months of life to minimally symptomatic course for 10 to 20 years and extended survival. An increasing number of patients with CF live into the sixth and seventh decades of life.6,7,12
Cough is usually the earliest symptom and is usually worse at night. At first it is intermittent and occurs with what appears to be an acute respiratory illness. The coughing is sometimes accompanied by wheezing, especially in infants and young children. Episodes of coughing persist longer than expected for a routine respiratory illness and occur more frequently with time. As the disease progresses, the cough becomes productive of thick purulent sputum. Symptoms consistent with bronchitis may occur for several years before diagnosis. Eventually the exacerbations of productive cough are accompanied by dyspnea, anorexia, and weight loss. Physical findings depend on the stage of the disease. At first crackles are intermittent and occur with exacerbations. Lung sounds may be decreased because of hyperinflation. As the disease progresses, rales and rhonchi are common and continuous.8 The majority of adults with CF die of respiratory failure.
Patients who have not yet been diagnosed with CF may initially be seen at any age and can present with a variety of complaints. Many symptoms can mimic those found in a variety of other diseases. Failure to thrive and a history of chronic respiratory, and/or gastrointestinal problems are the most common symptoms in children. A child may have persistent cough or recurrent pneumonia and atelectasis. Atypical asthmatics with digital clubbing (which occurs in nearly all patients with CF), bronchiectasis, or cough producing sputum may potentially have CF. Undiagnosed cystic fibrosis patients may have been seen in the emergency department or primary care physician's office multiple times for respiratory or GI complaints, yet the diagnosis remains elusive. CF won't be diagnosed in patients with mild disease or older patients unless someone puts the pieces together and refers the patient for testing. This is an important role for the emergency physician.
Patients diagnosed with CF as adults usually present with chronic respiratory problems. As a group, they have milder lung disease, less Pseudomonal infection, and are more likely to be pancreatic-sufficient than patients diagnosed at an earlier age.13-15 Adult patients come to attention with atypical presentations such as chronic/recurrent pancreatitis, recurrent pneumonia, or bronchitis.3,16-18
A newborn may have a meconium ileus while older children and adults can present with frequent passage of pale, bulky, loose, and excessively foul-smelling stool that is characteristic of CF. Young patients are often misdiagnosed as having milk allergy or chronic diarrhea and may have tried multiple different formula preparations. Edema and hyponatremia may develop in children with CF, especially those taking a soy protein formula. Bleeding problems resulting from vitamin K malabsorption may be seen. Many patients presenting with less severe symptoms may not require emergency treatment at all. These patients, however, must be referred for further diagnostic evaluation if the suspicion of CF is high.
Pulmonary Disease. Changes consistent with airway obstruction appear first in the small airways along with evidence of airway hyperactivity. Arterial oxygenation decreases with time. As the disease progresses, untreated hypoxemia and progressive loss of functional lung may produce pulmonary artery hypertension and right ventricular failure (cor pulmonale). Hypercarbia and chronic respiratory acidosis are apparent in late stage disease. Respiratory failure becomes increasingly difficult to manage at this point.
The lung function in adults with CF is highly variable. FEV1 expressed as the percentage predicted of a healthy nonsmoking reference population is accepted as the single most useful objective measure of pulmonary status.19 Thirty-six percent of adults with CF have normal or mild lung dysfunction (FEV1 > 70% predicted). Thirty-nine percent have moderate dysfunction (FEV1 < 40% to 69%). The remainder have severe dysfunction (FEV1 < 40% predicted).3
The lungs of CF patients are colonized and infected by bacteria from an early age. Pseudomonas aeruginosa is the most common pathogen, infecting most of the CF population.20 In fact, persistent bacterial pulmonary infection, especially with Pseudomonas aeruginosa, is the hallmark of CF. The mucoid strains of Pseudomonas are associated with more rapid clinical deterioration. Although mucoid P. aeruginosa is occasionally cultured from patients with other lung diseases, its presence in the sputum should immediately alert the physician to the possibility of cystic fibrosis. Other common pathogens encountered include S. aureus, H. influenzae, Stenotrophomonas maltophilia, Burkholderia cepacia, and non-tuberculous mycobacteria.21 As the disease progresses, infection with antibiotic resistant bacteria and concomitant infection with more than one organism are likely.8 Burkholderia cepacia is a multiple resistant gram negative organism that carries the worst prognosis. Some patients who develop a sepsis-like syndrome with severe necrotizing pneumonia called cepacia syndrome have rapid deterioration and death.1
The most frequent fungal infection seen is Candida, affecting 50-70% of patients. Aspergillus is isolated from 25% of patients and can be associated with significant allergic manifestations such as wheezing, pulmonary infiltrates, and worsening of bronchiectasis and fibrosis.22 More than 50% patients have antibodies to Aspergillus fumigatus, but only a small percentage develop allergic bronchopulmonary aspergillosis. This is characterized by rusty brown sputum plugs.8
These organisms, which often spread among individuals with CF, thrive in the altered mucus in the small airways of the lungs. This mucus encourages the development of bacterial microenvironments called biofilms that are difficult for immune cells and antibiotics to penetrate. CF disease progresses from bronchiolitis at a young age to bronchitis and eventually bronchiectasis as a consequence of persistent obstruction and inflammation. Bronchiectatic cysts are prominent in 50% of lungs in end stage patients and may contribute to the 3-19% reported incidence of pneumothorax.1,8
In general, adults with CF have more severe pulmonary disease than children. Adults are at higher risk for serious complications such as pneumothorax and massive hemoptysis.
Chronic airway infection leads to significant, persistent neutrophilic inflammatory response that destroys small airways, leading to bronchiectasis. Angiogenesis in areas of intense inflammation predisposes patients to hemoptysis, which occurs in about 3% of adult patients per year. Hemoptysis, which usually presents as blood-streaked sputum, becomes more common as bronchiectasis develops. Significant hemoptysis is 30-60 cc of blood and is due to the erosion of an area of local bronchial infection or bronchiectasis compromising a bronchial vessel. Hemoptysis is usually self-limited, but embolization or lobectomy may be required in severe cases.1 Hemoptysis may require supplemental vitamin K if the prothrombin time is prolonged due to inadequate absorption.24
Pneumothorax is a well-known complication whose incidence increases with age. Sixteen to 20% of CF adults have a pneumothorax at some point, often as the result of rupture of a subpleural bleb. The patient usually presents with chest pain, dyspnea, and hemoptysis. CF patients with a pneumothorax of greater than 10% should be treated with a tube thoracostomy as 30% of these patients are reported to experience a tension pneumothorax.1,8
Additional diagnoses such as asthma, allergic bronchopulmonary aspergillosis, sinus disease, and gastroesophageal reflux should be considered in patients whose clinical course of respiratory decompensation or response to treatment are atypical for CF.
Loss of CFTR function also affects the upper airway epithelium, so chronic rhinitis is common. The sinuses are universally involved but acute/chronic sinusitis is uncommon.
Cardiac Disease. Patients with CF who have moderately severe pulmonary insufficiency and some degree of hypoxia will eventually develop right ventricular hypertrophy secondary to pulmonary hypertension (cor pulmonale). Increased hypoxia during an exacerbation of pulmonary symptoms in such patients may precipitate an episode of congestive heart failure. In addition to cyanosis, tachypnea, and tachycardia, other associated symptoms may include an enlarged, tender liver and ascites.25
Gastrointestinal Disease. Failure to secrete enough chloride and fluid in the intestine leads to reduced water content of the fecal stream, which results in meconium ileus in many infants with CF. The abnormal intestinal mucus in CF patients leads to a decrease in mobility that, combined with a decreased amount of abnormal pancreatic and biliary secretions, results in a dry, thick stool that cannot pass from the terminal ileum to the cecum. This may cause recurrent abdominal pain, obstruction, volvulus, or intussusception. In older patients, distal intestinal obstruction syndrome or "meconium ileus equivalent" can produce intermittent recurrent episodes of partial small bowel obstruction in 15% of patients and may lead to complete obstruction.1 Distal intestinal obstruction syndrome can be relieved with intestinal "flushes" with a balanced salt solution of 1-2 liters instilled into the stomach. Rectal prolapse may be seen in adults and can usually be reduced voluntarily by using abdominal, perianal, and gluteal muscles.6
Gastroesophageal reflux disease (GERD) is common in CF patients, and is seen in more than 20%.26 Many factors contribute, such as head down position for airway clearance, medications that decrease lower esophageal sphincter tone, and hyperexpansion of the lung that flattens the diaphragm and impairs the physiologic sphincter.27
Destruction and loss of pancreas function occurs at birth or in early infancy. Exocrine pancreas disease affects most CF patients; 91% are on pancreatic replacement therapy.27,28 Obstruction of the ducts, loss of acinar cells, and pancreatic enzyme deficiency leads to malabsorption of protein, fat, and fat-soluble vitamins. This leads to bulky, foul-smelling stool and weight loss.8 Abnormal CFTR function in the ducts of the pancreas causes a decreased volume of secretions with reduced bicarbonate concentration. Autoactivation of retained digestive proenzymes leads to destruction of pancreatic tissue. Consequently, absorption of fat soluble vitamins A,D,E, and K is reduced. The presence of pancreatic insufficiency portends a worse overall prognosis.
Symptoms of pancreatitis occur in a small percentage of adolescents and adults, especially in those who have retained pancreatic function. There is a strong association between idiopathic pancreatitis and having one CFTR mutation.29 Although the Islets of Langerhans are relatively spared, destruction of the pancreas can cause endocrine pancreatic dysfunction leading to diabetes. This rarely develops before the age of 10 and usually manifests after the second decade of life. The prevalence of CF-related diabetes increases with age from 9% (age 5-9) to 43% for patients over 30 years of age.30 Hyperglycemia can occur at any age but is generally a problem of the second and third decades of life.31 Diabetic ketoacidosis is rare in CF-related diabetes. Most patients with sustained hyperglycemia require insulin, but oral agents may work in some patients.
Liver disease is the second most common cause of death in CF patients.28 Many CF patients have some form of liver or biliary disease.8 This may manifest as elevated transaminases, hepatosteatosis, or gall stones. Frank liver disease with cirrhosis and liver failure can occur in childhood and is progressive. As patients are living longer, chronic obstruction of the ducts may lead to liver damage and biliary cirrhosis. Hematemesis is a severe complication that may develop from esophageal varices due to portal hypertension. The severity of liver disease varies widely from mild elevation of alkaline phosphatase in many patients to hepatomegaly and persistently elevated liver enzymes to jaundice, ascites, and edema in severe cases. However, few patients develop clinical cirrhosis. Thirty percent of adult CF patients have a hypoplastic, poorly functioning gallbladder and may develop gallstones.1,3
There is an increased risk of Crohn's disease by 12-fold in CF patients over the general population as well as a 6-fold increase risk of malignancy.32,33
Genitourinary Disease. Atrophy of the Wolffian duct structures is almost universal in CF patients. Ninety-five percent of young men with CF are infertile because of bilateral absence of the vas deferens, abnormalities of the seminal vesicle, or both.34 It is believed that the vas deferens becomes occluded during gestation and is reabsorbed. Spermatogenesis is retained, however, and retrieval of sperm for in vitro fertilization can be performed. Females with CF have decreased fertility because of thick secretions at the cervical os and poor nutritional status.34-36
Emergency Department Evaluation and Treatment
Radiographs. Hyperinflation is often the earliest change seen on chest radiograph. Subsequent peribronchial thickening creates peribronchial cuffing. As the disease progresses, mucus impaction and bronchiectasis are seen as well as variable amounts of fluffy infiltrates. The right upper lobe is usually the first and most severely involved. Widespread bronchiectasis may be seen on CT before it appears on plain chest radiographs.8
A chest radiograph is indicated for patients with suspicion for an acute complication, such as pneumonia or pneumothorax. Comparison to old films is important to note acute changes. Chest CT is indicated for patients presenting with complications such as loculated pleural effusions, lung abscess, or other potentially surgical problems.
Laboratory evaluation is complaint-specific may include complete blood count, basic metabolic panel, transaminases, coagulation studies, and arterial blood gases.
The cornerstones of emergency treatment in CF are similar in adults and children. This includes oxygen, airway support, antibiotic treatment (acute, chronic, or suppressive), airway clearance, mucolytic therapy, anti-inflammatory agents, and bronchodilators.
Oxygen. Supplemental oxygen should be used as needed to maintain adequate oxygenation in the acute setting. Supplemental oxygen in accordance with the guidelines established for chronic COPD is recommended.37,38 The most important chronic therapy for the prevention of pulmonary hypertension is supplemental oxygen.
Antibiotics. Pulmonary exacerbations are common in adults with CF and usually are associated with bacterial infections. There is evidence that early, aggressive use of antibiotics in decompensated CF patients produces better results than delaying the administration of antibiotics until symptoms are well developed or advanced.39 The choice of antibiotics and the use of single or combined therapy are controversial areas in the treatment of respiratory infection in CF. A recent Cochrane review investigated single vs. combination intravenous antibiotic therapy for CF patients. The results were inconclusive due to multiple trials, variable antibiotic choices, and significant methodological issues.40
Although P. aeruginosa is rarely eradicated once it becomes chronic, an important benefit is gained by decreasing the net bacterial load with intensive parenteral antibiotics. As the number of organisms decreases, airway inflammation is reduced, thus decreasing the airway destruction and the airway symptoms. Azithromycin has no direct killing effect against Pseudomonas but it can adversely affect Pseudomonas virulence factors and it is active against H. influenzae and S. aureus.41 There is evidence that the macrolides demonstrate acute inflammatory effects such as modulation of signaling pathways, inhibition of proinflammatory cytokines, limiting influx of neutrophils to the lung, mucus secretion, and altering the formation of the biofilm matrix.41-43
Long-term macrolide antibiotics effectively treat diffuse panbronchiolitis and produce clinical improvement in patients chronically infected with Pseudomonas. Azithromycin has been shown in 4 randomized controlled trials to improve lung function and reduce the frequency of pulmonary exacerbations,42,44-46 even prior to infection with Pseudomonas.
Antibiotics are selected on the basis of recent sputum cultures, if available, although this is not often the case in the emergency department. Therapy with fluoroquinolones is often used for mild to moderate exacerbations in adults. Two antipseudomonal antibiotics are used in combination (ie. Beta lactam and aminoglycoside) for the treatment of moderate to severe exacerbations.3 (See Table 4 for suggested antibiotic regimens.)
Aminoglycosides have been the mainstay of anti-Pseudomonas therapy for many years and may still have a role in some patients. A major advantage is the ability to monitor and adjust blood levels. Disadvantages include oto- and nephrotoxicity. A drug like gentamycin or tobramycin is usually paired with one of the penicillin derivatives or with ceftazidime.26 Clearance of aminoglycosides by the kidney is increased in CF. The re-quired doses are often two to three times higher than in non-CF patients.8
Inhalation antibiotics are attractive because high concentrations can be attained at the airway surface and in mucus, thereby minimizing systemic toxicity. Aerosolized high-dose tobramycin (TOBI) can reduce the density of P. aeruginosa, improve FEV1, and reduce length of hospitalization.47
Chronic suppressive antibiotic therapy is increasingly becoming a standard part of care.
Aerosolized tobramycin is the most thoroughly studied chronic suppressive therapy. In two large double blind placebo controlled trials, treatment with TOBI was found to produce significant improvement in pulmonary function, to decrease the density of P. aeruginosa in the sputum, and to decrease the number of days the patients were hospitalized.45 Chronic, continuous, low-dose azithromycin also improves lung function and reduces the frequency of exacerbations.48,49
CF patients require higher doses of antibiotics and shorter dosing intervals. In general, the highest recommended doses are given to achieve penetration into the respiratory secretions. Both total body clearance and volume of distribution are considerably greater for CF patients than other patients.50 In addition, large doses are needed to achieve therapeutic levels in the infected and mucus- or pus-filled endobronchial space. Longer courses of 2-4 weeks of antibiotics are often used.
Chest Physiotherapy. Excessive bronchial secretions contribute to the airway obstruction in CF, which leads to atelectasis and hyperinflation. For 40 years, chest physiotherapy (CPT) was the major airway clearance strategy in CF. The goal of CPT is to improve pulmonary status and prolong survival via removal of tenacious bronchial secretions, reduce airway resistance, and improve ventilation over the short term.51 Chest PT facilitates loosening and expectoration of mucus. CPT is often initiated in asymptomatic patients to try to slow the progression of the disease.
The most compelling argument for the use of postural drainage with chest percussion (based on the concept that cough clears mucus from large airways but chest vibrations are necessary to move secretions from the small airways where expiratory flow rates are low) comes from a study of older children with mild-moderate airflow limitation.52 When patients were receiving CPT on a regular basis, the only immediate effect was an increase in peak expiratory flow rate 30 minutes after therapy. However, after 3 weeks without CPT, both functional vital capacity (FVC) and flow rates were significantly reduced. A meta-analysis of 35 studies concluded that standard CPT increases sputum production and improves expiratory airflow (FEV1).39
A widely used device for chest compression therapy is called the vest. It is a chest wall compression and oscillation system that is composed of a fitted vest and oscillation system coupled to a pneumatic compressor. Therapy is delivered to the entire chest at the same time with the patient in a seated position. This allows for the administration of nebulized medications during therapy and also affords independence to the patient.3
CPT may be utilized as part of acute therapy in the emergency department. This may be performed by a respiratory therapist or trained family member.
Bronchodilators. The majority of CF patients have bronchial hyperreactivity/bronchospasm at least some of the time.42 Bronchodilators are a standard component of the therapeutic regimen, and most emergency physicians are very familiar with the use of these medications. They are often used in conjunction with CPT to facilitate airway clearance. There is some evidence that maintenance albuterol reverses the progressive downhill course in lung function in CF patients.53-55
Anticholinergic bronchodilators may be helpful in some patients with CF. Ipratropium may be more effective than beta agonists in adults with CF. Adults often have less bronchospasm, but more secretions than children. The airway of the adult CF patient may closely mimic that of the adult with chronic bronchitis and, therefore, may be more responsive to the effects of a parasympathomimetic agent. Combination therapy with a beta agonist may also be effective.56-58
Hypertonic Saline. The excessive absorption of salt from the airway lumen of CF patients carries water with it, dehydrating airway mucus secretions and depleting the volume of liquid on the airway surface. These changes disrupt the mucociliary mechanism, and the retained mucus becomes a nidus for chronic infection.59 Therefore it is hypothesized that the use of hypertonic saline should be helpful in CF patients.
Over the short term, hypertonic saline (HS) improves the transportability of sputum and hydration of the airway surface60,61 and mucociliary clearance and lung function62,63 in patients with CF. Treatment with hypertonic saline for one year had no significant effect on the rate of decline in lung function, but it was associated with a moderate yet sustained improvement in the level of lung function. More dramatic were the reductions in the number of exacerbations, antibiotic use for exacerbations, and absenteeism from school/work.59
In a double blind study of 164 patients 6 years old or older with stable CF, patients inhaled 7% saline or normal saline twice a day for 48 weeks. The hypertonic group had significantly higher functional vital capacity (FVC) (by 82 cc, 95% CI 12-153) and FEV1 (by 68 cc, 95% CI 3-132). In addition, the hypertonic saline group had fewer pulmonary exacerbations (relative reduction of 56%, p = 0.02) and a higher percentage of patients without exacerbations (76% vs 62%, p = 0.03).59
Hypertonic saline, usually preceded by a bronchodilator, is inexpensive, safe, and effective therapy for patients with CF and can safely be used as part of the treatment in the emergency department.
Mucoactive Therapies. The most characteristic feature of inflammation in the lung is the persistent infiltration of massive numbers of neutrophils into the airway. Although neutrophils help control infection, when present in excess, they may cause more harm than good.65 Neutrophils infiltrating the airways and degenerating are the major source of the DNA and filamentous actin that makes CF sputum so tenacious.66,67 Augmentation of DNA content is directly associated with an increase in mucus viscosity.68 Mucoactive therapies reduce viscosity and tenacity of the sputum via degradation of the excess DNA. The most widely used agent for this purpose is dornase alpha (Pulmozyme).51
DNase is produced naturally in humans. More than 50 years ago, it was shown that bovine pancreatic deoxyribonuclease I (DNase I), an enzyme that cleaves DNA, reduced the viscosity of lung secretions in vitro.69 It was approved for human use in 1958. The agent lost popularity over time due to severe pulmonary reactions, possibly allergic in etiology. Recombinant human DNase (also known as alpha-dornase or Pulmozyme,) was sequenced in 1990 and used in aerosolized form. It decreases the viscosity of CF sputum by catalyzing extracellular DNA into smaller fragments.70 This preparation has better tolerability, with the most common adverse effects being respiratory such as pharyngitis and hoarseness with minor allergic reactions.51 The drug can be started safely during an acute pulmonary exacerbation, as well as during a stable period.71
A study of rhDNase in patients 3-16 years old showed that one-third children had sustained improvement in spirometry greater than 20% over 1 year, but one-third deteriorated.72 The effects of rhDNase on lung function diminish over time. Another study showed that after stopping rhDNase, lung function dropped markedly below the initial baseline level.51 The concern is that rhDNase only effects a superficial removal of secretions while deeper down below the mucosal surface, tissue damage continues as before. The dose is 2.5 mg nebulized once or twice daily.51
Ballman, et al., compared nebulized rhDNase to hypertonic saline in a short-term study of 14 patients with mild to moderate CF. They demonstrated comparable short-term effects and noted that hypertonic saline was much cheaper. A longer trial with 48 patients demonstrated that rhDNase produced significantly greater improvement in FEV1 from baseline compared with hypertonic saline.73
There are no other well-validated alternative mucolytic agents available presently. IV acetylcysteine reduces the viscosity of sputum in vitro but can be very irritating to the upper airway and can cause bronchoconstriction.74 Further investigation is ongoing.
To the authors' knowledge, no randomized controlled studies exist to support the efficacy of nebulized DNase in the emergency department for acutely decompensated pulmonary disease in CF patients. However, it is a reasonable addition to acute therapy in a CF patient in whom intubation is an undesirable option.
Steroids. Oral corticosteroids have a wide range of anti-inflammatory effects, one of which is to prevent the conversion of neutrophils to the activated state. They also prevent the production of toxic metabolites.41 Two randomized controlled trials in CF patients with mild to moderate disease treated with 1 or 2 mg/kg prednisone on alternate days for a 2-4 year period showed improvements in lung function and reduction in frequency of pulmonary exacerbations compared to placebo.75,76
Short-term treatment (3 weeks) with daily corticosteroids in stable patients with severe obstructive disease showed no benefit,77 but patients with less severe disease showed some improvement.78 The 1 mg/kg group vs placebo for 4 years had benefit with respect to pulmonary function at the expense of growth impairment and bone density.79,80
The long-term adverse effects are well-described and include glucose intolerance, cataracts, and growth impairment. An increase in the rate of infection is not seen.76,81 Inhaled steroids have less systemic effects. Low doses of inhaled beclomethasone showed no effect on various markers of airway inflammation.82 Higher doses of inhaled steroids have shown promise in preliminary studies.83,84 Larger trials with long-term data are needed.
Advanced Airway Management. Hypercapnic and hypoxemic respiratory failure in CF is primarily due to progressive obstructive airway disease with alveolar hypoventilation with ventilation-perfusion mismatch. When a CF patient presents in respiratory failure, the management decisions become difficult. CF patients in general do not respond as well to and have more complications from mechanical ventilation compared to COPD patients.25 However, ventilatory assistance is effective in CF patients with acute respiratory failure caused by reversible insults,40 but produces few long-term benefits in patients with respiratory failure due to irreversible bronchiectasis.85 The difference between these two entities may not be easy to determine the emergency department setting. Aggressive ICU care for adults with CF who have respiratory failure as a consequence of progression of their disease can be beneficial.86 If an acute episode such as pneumonia or bronchospasm precipitates respiratory failure in a CF patient who had good pulmonary function before the episode, mechanical ventilation should be considered.25 Factors to consider when making the decision: the patient's level of activity and pulmonary function before the episode, the cause of the patient's decompensation, and the expectations of patient and his or her family. Ventilatory support is appropriate for a patient when lung transplant is planned.86 Consult with the patient's personal physician before electing not to intubate a patient.
Avoidance of endotracheal intubation and mechanical ventilation is desirable to limit possible airway complications of intubation, including nosocomial pneumonia and deleterious cardiovascular effects of positive-pressure ventilation such as decreased cardiac output or pneumothorax. Alternative ventilatory support in the form of BIPAP may be useful. Bilevel positive airway pressure (BIPAP) is a noninvasive mode of ventilation administered through a tight-fitting mask to assist spontaneously breathing patients. The BIPAP system regulates the pressure supplied to patients, delivering different pressures during inspiration and exhalation. As the patient initiates a breath, the system delivers air with a positive pressure gradient, thus increasing tidal volume and minute ventilation.87,88
BIPAP has been used in cystic fibrosis as a bridge to transplantation. It has been shown that the use of BIPAP is associated with improvement in ventilation and arterial blood gases as well as improvement in subjective symptoms such as headaches, activity level, and quality of sleep in CF patients with end-stage lung disease awaiting lung transplant.89,90 In a small study, Efrati, et al., demonstrated a significant improvement in survival of CF patients after lung transplant for patients who used BIPAP in the months before lung transplantation compared with those who did not use BIPAP. This improvement was thought to be due to improvement in respiratory muscle strength and nutritional status.87
Patient cooperation is crucial to the success of BIPAP. It is not recommended for patients with altered mental status, abnormal gag reflex, inability to protect airway, or inability to effectively clear respiratory secretions or protect their airway.
Heliox has been used with some success in asthmatic patients with severe airway obstruction.19,91 The literature describing the use of heliox in cystic fibrosis is very limited. It was used in conjunction with noninvasive high-frequency percussive ventilation in a 5-year old child with severe acute respiratory failure resulting from advanced cystic fibrosis lung disease. The patient had dramatic improvement and avoided intubation in that case.19 Another case report details the successful use of heliox in a teenage girl with severe acute respiratory compromise from cystic fibrosis.92 The mechanism of action is thought to be improvement of gas exchange by enhancing molecular diffusion and by favoring laminar flow throughout the upper and lower airways. Further study is needed, but this seems like a reasonable therapeutic alternative for an acutely decompensated cystic fibrosis patient.19,86,91
Promising Therapies. Over the last 50 years the Cystic Fibrosis Foundation has been at the forefront of research efforts for the development of potential CF therapies. CF, however, is still a complicated and uniformly fatal disease. Novel treatments can be divided into two basic categories: those aimed at correction of the CFTR dysfunction and those aimed at mitigating the effects of having a limited number of CFTR channels. Definitive cure for CF would involve correcting the deficit left by the CFTR gene mutation. Restoration of even 5-10% of airway epithelial cells could correct the electrolyte transport defect.8 There has been a significant amount of promising research in this direction, including gene therapy, activation of alternate chloride channels, and improving function of native CFTR.1
Ibuprofen can slow the effects of CF by reducing inflammation, but long-term use of this drug at the high doses required for improvement can negatively affect the kidney and gastrointestinal tract as well as other organs. The use of N-acetylcysteine as an alternate method to reduce inflammation is being investigated. High-dose oral N-acetylcysteine (NAC), a glutathione prodrug, modulates inflammation in cystic fibrosis. NAC has been tested with some success in patients with other inflammatory lung problems, including chronic bronchitis, chronic obstructive pulmonary disease, and idiopathic pulmonary fibrosis.93 Oral NAC treatment not only increased the amount of glutathione in circulating neutrophils, it also decreased the number of neutrophils and the levels of elastase and interleukin-8 in the airways. In 2006 the researchers began a 24-week placebo-controlled Phase II trial of NAC in cystic fibrosis patients to confirm these findings.93
In the terminal phases of the disease, lung transplantation often becomes necessary for individuals with CF as lung function and exercise tolerance declines. A pancreatic or liver transplant may be performed at the same time to alleviate liver disease and/or diabetes. Lung transplantation is considered when lung function approaches a point where it threatens survival or requires assistance from mechanical devices.
The literature describing emergency department care of the acutely decompensated cystic fibrosis patient is sparse. Many pediatricians and pulmonologists work diligently to keep the patients out of the emergency department with care in the clinic and at home. If the patient needs to come to the ED, hospital admission is usually the goal.
The most important indications for admission would include need for intravenous antibiotics and/or advanced airway management. The disposition of the patient should include input from the patient's primary care physician or pulmonologist.
For patients who are not transplant candidates and have progressive respiratory failure, it may be difficult to decide whether to offer intubation. Potentially reversible aspects of the disease, short-term goals, and the wishes of the patient and the family are important to consider.86 In patients who are not transplantation candidates, the decision to proceed with mechanical ventilation should be undertaken with the understanding that there is a limited chance for a good outcome.94 For terminal patients in whom mechanical ventilation is not planned, the primary palliative care issue is the management of dyspnea. Morphine infusions have been successfully used in these cases to provide comfort care.94 Advanced directives are helpful in this situation and should be sought.
1. Strausbaugh SD, Davis PB. Cystic fibrosis: A review of epidemiology and pathobiology. Clin Chest Med 2007;28:279-288.
2. Anderson D. Cystic fibrosis of the pancreas and its relation to celiac disease. Am J Dis Child 1938;56:344-389.
3. Yankaskas JR, Marshall BC, Sufian B, et al. Cystic fibrosis adult care. Consensus conference report. Chest 2004;125:1S-39S.
4. Elborn JS, Shale DJ, Britton JR. Cystic fibrosis: current survival and population estimates to the year 2000. Thorax 1991;46:881-885.
5. Cystic Fibrosis Foundation website (www.cff.org). Accessed January 25, 2008.
6. Boucher RC, Knowles MR, et al. Cystic fibrosis; chapter 38. In: Mason RJ, Murray JF, eds. Murry and Nadel's Textbook of Respiratory Medicine, 4th ed. Philadelphia: Elsevier Saunders; 2005.
7. di Sant'Agnese PA, Davis PB. Cystic fibrosis in adults: 75 cases and a review o 232 cases in the literature. Am J Med 1979;66:121-132.
8. Walsh MJ. Cystic fibrosis. In: Goldman L, Ausiello D, eds. Cecil Medicine, 23rd ed. Philadelphia: Saunders Elsevier; 2008: 627-631.
9. Sweat Testing Sample Collection and Quantitative Analysis, Approved Guideline Document C34-A, Wayne PA, National Committee for Clinical Laboratory Standards, 1994.
10. LeGrys VA. Sweat testing for the diagnosis of cystic fibrosis: Practical considerations. J Pediatr 1996;129:892-897.
11. Davis PB, Del Rios, Muntz JA, et al. Sweat chloride concentrations in adults with pulmonary diseases. Am Rev Respir Dis 1983;128:34-37.
12. Stern RC, Boat TF, Doershuk CF, et al. Cystic fibrosis diagnosed after age 13: Twenty-five teenage and adult patients including three asymptomatic men. Ann Intern Med 1977;87:188-191.
13. Elborn JS, Shale DJ, Britton JR. Cystic fibrosis: Current survival and population estimates to the year 2000. Thorax 1991;46:881-885.
14. Gan KH, Geus WP, Bakker W, et al. Genetic and clinical features of patients with cystic fibrosis diagnosed after the age of 16 years. Thorax 1995;50:1301-1304.
15. Widerman E, Millner L, Sexauer W, et al. Health status and sociodemographic characteristics of adults receiving a cystic fibrosis diagnosis after age 18 years. Chest 2000;118:427-433.
16. Cohn JA, Friedman KJ, Noone PG, et al. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med 1998;339: 653-658.
17. Sharer N, Schwarz M, Malone G, et al. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 1998;339:653-658.
18. Wang X, Moylan B, Leopold DA, et al. Mutation in the gene responsible for cystic fibrosis and predisposition to chronic rhinosinusitis in the general population. JAMA 2000;284:1814-1819.
19. Stucki P, Scalfaro P, de Halleux Q, et al. Successful management of severe respiratory failure combining heliox with noninvasive high-frequency percussive ventilation. Crit Car Med 2002;30:692-694.
20. Schidlow DV, Taussig LM, Knowles MR. Cystic Fibrosis Foundation consensus conference report on complications of cystic fibrosis. Pediatr Pulmonol 1993;15:187-198.
21. Burns JL, Emerson J, Stapp JR, et al. Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin Infect Dis 1998;27: 158-163.
22. Greenberger PA. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2002;110:685-692.
23. Cystic fibrosis foundation. Patient registry 2000 annual data report. Bethesda, MD: Cystic fibrosis foundation, 2001.
24. Zielenski J, Tsui LC. Cystic fibrosis: genotypic and phenotypic variations. Annu Rev Genet 1995;29:777-807.
25. Scanlin TF. Cystic fibrosis. In: Fleisher GR, Ludwig S. Textbook of Pediatric Emergency Medicine, 4th ed. Lippincott Williams and Wilkins; Philadelphia: 2000; 1087-1092.
26. Scott RB, O'Loughlin EV, Gall DG. Gastroesophageal reflux in patients with cystic fibrosis. J Pediatr 1985;106:223-227.
27. Ferry G, Klish W, Borowitz D, et al. Consensus conference for GI problems in cystic fibrosis. Bethesda, MD; June 1991.
28. Cystic Fibrosis Foundation Patient Registry 2005 Annual Data Report to the Center Directors. Bethesda, MD: Cystic Fibrosis Foundation 2006.
29. Cohn JA, Friedman KJ, Noone PG, et al. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med 1998;339; 653-658.
30. Moran A. Cystic fibrosis-related diabetes: An approach to diagnosis and management. Pediatr Diabetes 2000;1;41-48.
31. Robbins MK, Ontjes DA. Endocrine and renal disorders in cystic fibrosis. Cystic fibrosis in adults. Philadelphia: Lippincott-Raven; 1999:383-418.
32. Floyd-Still JD. Crohn's disease and cystic fibrosis. Dig Dis Sci 1994;39: 880-885.
33. Neglia JP, Fitzsimmons SC, Maisonneuve P, et al. The risk of cancer among patients with cystic fibrosis. Cystic fibrosis and cancer study group. N Engl J Med 1995;332:494-499.
34. Auguiano A, Oates RD, Amos JA, et al. Congenital bilateral absence of the vas deferens: a primarily genital form of cystic fibrosis. JAMA 1992;267: 1794-1797.
35. Chillion M, Casals T, Mercier B, et al. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N Engl J Med 1995;331:1475-1480.
36. Mak V, Zielenski J, Tsui LC, et al. Proportion of cystic fibrosis gene mutations not detected by routine testing in men with obstructive azoospermia. JAMA 1999;281:2217-2224.
37. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease; nocturnal oxygen therapy trial group. Ann Intern Med 1980; 93:391-398.
38. Schidlow DV, Taussig LM, Knowles MR. Cystic Fibrosis Foundation consensus conference report on pulmonary complications of cystic fibrosis. Pediatr Pulmonol 1993;15:187-198.
39. Thomas J, Cook DJ, Brocks D. Chest physical therapy of patients with cystic fibrosis: A meta-analysis. Am J Respir Crit Care Med 1995;151:846-850.
40. Elphick HE, Tan A. Single versus combination intravenous antibiotic therapy for people with cystic fibrosis. Cochrane Database Syst Rev 2001; (1):CD002007.
41. Elston C, Geddes D. Inflammation in cystic fibrosis. When and why? Friend or foe? Semin Respir Crit Care Med 2007;28:286-294.
42. Clement A, Tamalet A, Leroux E, et al. Long-term effects of azithromycin in patients with cystic fibrosis: a double-blind, placebo-controlled trial. Thorax 2006;61:895-902.
43. Saiman L. The use of macrolide antibiotics in patients with cystic fibrosis. Curr Opin Pulm Med 2004;10:515-523.
44. Equi A, Balfour-Lynn IM, Bush A, et al. Long-term azithromycin in children with cystic fibrosis: A randomized, placebo-controlled crossover trial. Lancet 2002;360:978-984.
45. Saiman L, Marshall BC, Mayer-Hamblett N, et al. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa. A randomized controlled trial. JAMA 2003;290:1749-1756.
46. Wolter J, Seeney S, Bell S, et al. Effect of long-term treatment with azithromycin on disease parameters in cystic fibrosis: a randomized trial. Thorax 2002;57:212-216.
47. Ramsey BW, Pepe MS, Quan JM, et al. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. N Engl J Med 1999;340:23-30.
48. Equi A, Balfour-Lynn IM, Bush A, et al. Long-term azithromycin in children with cystic fibrosis. A randomized, placebo-controlled crossover trial. Lancet 2002;360:978-984.
49. Saiman L, Marshall BC, Mayer-Hamblett N, et al. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: A randomized controlled trial. JAMA 2003;290:1749-1756.
50. Smith A, Cohen M, Ramsey B. Pharmacotherapy. Cystic Fibrosis in Adults. Philadelphia: Lippincott – Raven; 1999:354-364.
51. Suri R. The use of human deoxyribonuclease (rhDNase) in the management of cystic fibrosis. BioDrugs 2005;19:135-144.
52. Desmond KJ, Schwenk WF, Thomas E, et al. Immediate and long-term effects of chest physiotherapy in patients with cystic fibrosis. J Pediatr 1983;103:538-542.
53. Konig P, Gayer D, Barbero GJ, et al. Short-term and long-term effects of albuterol aerosol therapy in cystic fibrosis: a preliminary report. Pediatr Pulmonol 1995;20:205-214.
54. Hordvik NL, Sammut PH, Judy CG, et al. The effects of albuterol on the lung function of hospitalized patients with cystic fibrosis. Am J Respir Crit Care Med 1996;154:156-160.
55. Eggleston PA, Rosenstein BJ, Stackhouse CM, et al. A controlled trial of long-term bronchodilator therapy in cystic fibrosis. Chest 1991;99: 1088-1092.
56. Avital A, Sanchez I, Chernick V. Efficacy of salbutamol and ipratropium bromide decreasing bronchial hyperreactivity in children with cystic fibrosis. Pediatr Pulmonol 1992;13:34-37.
57. Weintraub SJ, Eschenbacher WL. The inhaled bronchodilators ipratropium bromide and metaproterenol in adults with cystic fibrosis. Chest 1989;95:861-864.
58. Sanchez I, Holbrow J, Chernick V. Acute bronchodilator response to a combination of beta-adrenergic and anticholinergic agents in patients with cystic fibrosis. J Pediatr 1992;120:486-488.
59. Elkins MR, Robinson M, Rose BR, et al. for the National Hypertonic Saline in Cystic Fibrosis Study Group. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med 2006;354: 229-240.
60. King M, Dasgupta B, Tomkiewicz RP, et al. Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease I. Am J Resp Crit Care Med 1997;156:173-177.
61. Wills PJ, Hall RL, Chan W, et al. Sodium chloride increases the ciliary transportability of cystic fibrosis and bronchiectasis sputum in the mucus-depleted bovine trachea. J Clin Invest 1997;99:9-13.
62. Robinson M, Regnis JA, Bailey DL, et al. Effect of hypertonic saline, amiloride and cough on mucociliary clearance in patients with cystic fibrosis. Thorax 1997;52:900-903.
63. Eng PA, Morton J, Douglass JA, et al. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis. Pediatr Pulmonol 1996;21: 77-83.
64. Gilbert DN, Moellering RC, Eliopoulos GM, et al, eds. The Sanford Guide to Antimicrobial Therapy 2007.
65. Konstan MW, Berger M. Current understanding of the inflammatory process in cystic fibrosis: Onset and etiology. Pediatr Pulmonol 1997;24:137-142.
66. Chernick WS, Barbero GJ. Composition of tracheobronchial secretions in cystic fibrosis of the pancreas and bronchiectasis. Pediatr 1959;24:739-745.
67. Potter J, Matthews LW, Lemmon J, et al. Composition of pulmonary secretions from patients with and without cystic fibrosis. Am J Dis Child 1960; 100:493-495.
68. Shak S, Capon DJ, Hellmas R, et al. Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum. Proc Natl Acad Sci USA 1990;87: 88-92.
69. Armstrong JB, White JC. Liquefaction of viscous purulent exudates by deoxyribonuclease. Lancet 1950;II:739-742.
70. Shak S, Capon DJ, Hellmiss R, et al. Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum. Proc Natl Acad Sci USA 1990;87: 9188-9192.
71. Wilmott RW, Amin RS, Colin AA, et al. Aerosolized recombinant human DNase in hospitalized cystic fibrosis patients with acute pulmonary exacerbations. Am J Resp Crit Care Med 1996;153:1914-1917.
72. Davies J, Trindale MT, Wallis C, et al. Retrospective review of the effects of rhDNase in children with cystic fibrosis. Pediatr Pulmonol 1997;23: 243-248.
73. Suri R, Grieve R, Normand C. et al. Effects of hypertonic saline, alternate day and daily rhDNase on healthcare use, costs and outcomes in children with cystic fibrosis. Thorax 2002;57:841-846.
74. Rao S, Wilson DB, Brooks RC, et al. Acute effects of nebulization of n-acetylcysteine on pulmonary mechanics and gas exchange. Am Rev Respir Dis 1970;102:17-25.
75. Auerbach HS, Williams M, Kirkpatrick JA, et al. Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis. Lancet 1985;2:686-688.
76. Eigen H, Rosenstein BJ, Fitzsimmons S, et al. A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group. J Pediatr 1995;126:515-523.
77. Pantin CF, Stead RJ, Hodson ME, et al. Prednisolone in the treatment of airflow obstruction in adults with cystic fibrosis. Thorax 1986;41:34-38.
78. Greally P, Hussain MJ, Vergani D, et al. Interleukin-1 alpha soluble interleukin-2 receptor and IgG concentrations in cystic fibrosis treated with prednisone. Arch Dis Child 1994;71:35-39.
79. Eigen H, Rosenstein BJ, Fitzsimmons s, et al. A multicenter study of alternate-day prednisone treatment in children with cystic fibrosis: Cystic Fibrosis Foundation Prednisone Trial Group. J Peditr 1995;126:515-523.
80. Lai HC, FitzSimmons SC, Allen DB, et al. Risk of persistent growth impairment after alternate-day prednisone treatment in children with cystic fibrosis. N Engl J Med 2000; 342:851-859.
81. Lai HC, FitzSimmons SC, Allen DB, et al. Risk of persistent growth impairment after alternate day prednisone therapy in children with cystic fibrosis. N Engl J Med 2000;342:851-859.
82. Schitotz PO, Jorgensen M, Flensborg EW, et al. Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis: A longitudinal study of immune complex activity and inflammatory response in sputum sol-phase of cystic fibrosis patients with chronic Pseudomonas aeruginosa infections: Influence of local steroid treatment. Acta Paediatr Scan 1983;72:283-287.
83. van Haren EH, Lammers JW, Festen J, et al. The effects of the inhaled corticosteroid budenoside on lung function and bronchial hyperresponsiveness in adult patients with cystic fibrosis. Respir Med 1995;89:209-214.
84. Nikolaizik WH, Schoni MH. Pilot study to assess the effect of inhaled corticosteroids on lung function in patients with cystic fibrosis. J Pediatr 1996; 128:271-274.
85. Davis PB. di Sant'Agnese PA. Assisted ventilation for patients with cystic fibrosis. JAMA 1978;239:1851-1854.
86. Sood N, Paradowski LJ, Yankaskas JR. Outcomes of intensive care unit in adults with cystic fibrosis. Am J Respir Crit Care Med 2001;163:335-338.
87. Efrati O, Kremer MR, Barak A, et al. Improved survival following lung transplantation with long-term use of bilevel positive pressure ventilation in cystic fibrosis. Lung 2007;183:73-79.
88. Matsui H, Grubb BR, Tarran R, et al. Evidence for periciliary fluid liquid layer depletion, not normal ion composition in the pathogenesis of cystic fibrosis airways disease. Nocturnal nasal intermittent positive pressure ventilation (BiPAP) in respiratory failure. Chest 1992;101:516-521.
89. Waldhorn RE. Nocturnal nasal intermittent positive pressure ventilation with bi-level positive airway pressure (BiPAP) in respiratory failure. Chest 1992; 101:516-521.
90. Efrati O, Modan-Moses D, Barak A, et al. Long-term non-invasive positive pressure ventilation among cystic fibrosis patients awaiting lung transplantation. Isr Med Assoc J 2004;6:527-530.
91. Rodrigo G, Pollack C, Rodrigo C, et al. Heliox for nonintubated acute asthma patients. Cochrane Database Syst Rev 2006; (4):CD002884.
92. Henchey K. Use of heliox therapy to relieve acute respiratory distress in an adolescent with cystic fibrosis: A case report. AM J Crit Care 2003;12: 556-557.
93. Tirouvanziam R, Conrad CK, Bottiglieri T, et al. High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis. Proc Natl Acad Sci 2006;103:4628-4633.
94. Robinson W. Palliative care in cystic fibrosis. J Palliat Med 2000;3:187-192.With advances in medical science, patients with serious congenital diseases are living into adulthood. Where once cystic fibrosis patients died in infancy, patients now live into their 40s. Although many of the standard treatments for COPD apply to cystic fibrosis, there are specific differences in management, which this monograph highlights.
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.

domain: literature


text:
All reviews are from people who have redeemed deals with this merchant.
What You'll Get
Choose Between Two Options
- $17 for $30 worth of Polish food for two or more
- $34 for $60 worth of Polish food for four or more
The Fine Print
Promotional value expires Jun 13, 2014. Amount paid never expires. Limit 1 per person, may buy 2 additional as gifts. Limit 1 per table. Limit 1 per visit. Valid for dine-in or carry-out. Merchant is solely responsible to purchasers for the care and quality of the advertised goods and services.
The inferno roaring inside Smak-Tak!'s cozy fireplace isn't the only thing the restaurant has to warm visitors' bones during long Chicago winters, as tables teem with bowls of thick traditional stews and hearty dumplings. Smak-Tak! translates as taste-yes!, a celebratory sentiment the cooks share through their classic pierogis, each stuffed with cheese and potato, plums, or sauerkraut and mushrooms. Hungarian-style pancakes sport toppings of gulash, while side salads frame chicken liver with onions.

domain: food


text:
May is where we catch up on our amazing Style Sessions to showcase our high school seniors! Excited to share the 2013 La Brisa Seniors with all of you!
Miss Lindsay, I am so happy to have photographed you and those baby blues. Thank you, thank you, thank you for choosing me for your senior photos; I had a blast hanging out with you!
To all of you aspiring photographers, autumn and I are teaching an Introduction to Portrait Photography Class on May 30th in Manhattan, KS! click this link – http://labrisaphoto.blogspot.com/2013/05/1-early-bird-spot-left-introduction-to.html for more details and to register for our class! 100% of profits are donated to a local and deserving non-profit organization!

domain: artistic


text: Event Directory Search for upcoming events Picks and Previews Plan ahead to check out these not-to-be-missed events All Theatre Dance Music Film & Media Visual Art Literary Festival Promotion Free Music Louis Lortie | Photo: Courtesy of CPO May 5, 2017 - May 6, 2017 French Classics Louis Lortie joins the Calgary Phil for a night of orchestra at its finest Amy Jo Espetveidt Location Jack Singer Concert Hall, Arts Commons 205 8th Ave. SE Price $25 - $85 Buy Tickets A spectacular showpiece that escalates into a whirlwind of dazzling arpeggios, esteemed pianist Louis Lortie joins the Calgary Philharmonic Orchestra for Saint-Saëns’ Piano Concerto No. 2. An ode to the French classics of Ravel, Saint-Saens, and Franck, the concert also features a visionary fusion of French and Germanic orchestral traditions, and showcases the orchestra at its finest. Quickly becoming known for his probing and vibrant interpretations of music of all periods, the show is conducted by special guest Maestro Matthew Halls. Catch French Classics featuring Louis Lortie at 8:00pm on May 5 and 6, 2017 at the Jack Singer Concert Hall, Arts Commons (205 8th Ave. SE).


I normally prefer thin socks, but when I do a lot of walking or hiking, I like a sock with a bit of cushioning on the bottom. Swiftwick’s Maxus Zero sock has been the perfect sock for my summer outings.
The Maxus Zero socks fit my feet perfectly. There’s no excess material or bunching. There’s a nice amount of cushioning on the bottom of the socks, and they stay in place all day long, thanks to a well-defined heel cup, a seamless toe area, and an ultra-thin and grippy area on top of the socks. I love never having to think about my socks because they’re so comfortable.
I like the below-ankle style, and the wicking and breathing properties of the Maxus Zero socks. My feet stay dry and never overheat. Thanks to the excellent wicking and breathing abilities of this sock (Swiftwick claims the fabric wicks 40% better than other socks), I can wear the socks a couple of times before washing.
Sizes: S, M, L. Available in several colors. Dark grey and dark grey with colored panels (Agua, Navy, Purple).
Materials: 66% Polyester, 22% Nylon, 10% Olefin, 2% Spandex. Made in the U.S.A.


text:
Sights & Attractions in The San Juan Islands
Things to Do in Orcas Island
The main town on Orcas Island lies at the head of...
This big, nonprofit activity center and museum is...
|Museums / Galleries||Orcas Island|
Moran State Park
This pristine patch of wildnerness comprises...
GREAT AMERICAN VACATION
Take our short photo quiz to reveal your ideal trip in the U.S.More
View deals in The San Juan Islands for vacation packages, hotels, airfare, and more from our partners!More

domain: geography


text:
Ghana is a long way from Portland, but to local musician, Okaidja Afroso, the gap is almost imperceptible.
Afroso grew up in Kokrobite, a small fishing village west of Ghana’s capital, Accra. Though he came from a family well known for their singing, Afroso was a dancer first. He worked and traveled with the Ghana Dance Ensemble at the University of Ghana’s Institute of African Studies, touring the U.S. and Germany and teaching about Ghanaian culture.
It was after a rehearsal one day that Obo Addy, a Portland-based musician who is also from Ghana, invited Afroso to be a part of his musical group, Okropong, in Portland. Afroso was in his early 20s when he packed his bags to make the move to the United States.
Today, Afroso is a vibrant and passionate performer and educator who combines the traditional music of his roots with where he is in the present. He teaches workshops and in schools across Oregon about Ghanaian music, stories, history, geography and language, sharing his culture, in the Ghanaian way, through music and oral tradition.
The idea behind his band Shokoto, he says, is to “find unique sounds.” The band plays music with roots in Ghana, and blends ideas from parts of South and Central America — true to a consummate student of the African diaspora. The sounds incorporate the Ga music from the Southern part of Ghana and the Dagomba music from the Northern part of Ghana.
In his native language Ga, Shokoto means a place of no hardship — a paradise, “a place where we would all like to be,” Afroso says, describing it as existing only in the heart.
Shokoto will perform at the Alberta Rose Theatre on Saturday, Aug. 25 for the release of his third album, “Messenger.”
Sue Zalokar: Tell us about the African diaspora and its impact on music.
Okaidja Afroso: The African diaspora brought so much music to the Americas. One might ask how they (slaves) were able to preserve that music for the longest time. It is through their drum language. Even though they were not able to play it, they could sing it. We practice the oral tradition. So many things that we know, many things that I know about my culture, I didn’t read in books. It was actually told to me, it was taught to me. It is my duty to teach it to someone else by speaking it to them, by singing it to them, by playing it to them.
S.Z.: You have spent much time in rural and urban communities performing and running workshops. Are there any similarities between rural Ghana and rural United States?
O.A.: There are some similarities. For one, everybody knows everybody. There is something that is really strong about rural communities in Ghana. There is lots of togetherness in terms of how they do things and I think one of the main reasons is music and dancing. When somebody passes, or a baby is born, there will be tons of drummers. And they will be playing and everybody in the community will for sure be there and dancing or listening. Everybody comes together. Sometimes I feel there a bit of disconnect in some of the rural towns here. It is just cultural differences. It is not good or bad. It’s just how we live differently.
S.Z.: You have lived, traveled and performed around the globe. In your opinion, is poverty universal?
O.A.: It is. Poverty can be looked at in many different ways. People who are very rich, but lack a strong cultural background are poor. Poverty doesn’t only come in terms of monetary worth. Every country has a strong culture, but if you disconnect from that culture, thn you are going to hurt your legacy. There is nothing to really pass on. That is poverty. The greater poverty is people who don’t have money and don’t have food. In many parts of Ghana, there are many people who don’t have anything but they find time to enjoy life. I think they are rich in many ways.
S.Z.: How does Ghanaian culture and society address issues of homelessness and /or mental illness?
O.A.: You will see people who are mentally ill in big cities like Accra. I think the country could do better taking care of the mentally ill so that they are not in the street. In term of homelessness, the rate is not huge. And in the small towns, families take care of each other. The town I grew up in, there was nobody who was homeless. There was absolutely no one. You’re going to live with someone. There will be somewhere where you are crashing and you will be welcome.
S.Z.: Storytelling is a huge part of the traditions of your people. Do you have a favorite story that you like to tell?
O.A.: The folk tales, when it comes to that, in Ghana we have all the stories about Anansi (the prankster spider). When you go to a school room, you will find many books about Anansi. The story originated from Ghana and neighboring countries like Togo and Nigeria. We all have similar stories about Anansi the spider. Every school in America has stories about Anansi.
Many times when I was growing up in the evening, we would sit around and people would be telling stories. We do that until we fall asleep. I grew up in a town with no electricity. We used kerosene lamps. No TV. We never had TV. I never had a toy that I would say, this is my toy. But I never felt like I should have gotten a toy from my mother. It didn’t matter. But at school, when we had lunch break, I could see the ocean. And I swam there everyday and I was able to catch the biggest waves.
S.Z.: You combine elements of the modern and traditional worlds in your dance, stories and music. How do the modern and traditional worlds interact?
O.A.: It is growing and growing. About three years ago I started to go to Fairbanks a lot and I met two gentlemen who play American roots music. Very good musicians. One is Raymond McLain and the other one a Canadian harmonica virtuoso Mike Stevens (he appears on Afroso’s album, “Messenger”). We became really good friends. One day they asked me to play with them. I didn’t know them, they were so humble. We went to play and I realized that these guys were crazy. Raymond plays the banjo. His family was the McLain Family Band. He is in the American books among the best banjo players. I was playing with them, and I was playing my Ghanaian music as I would play it and it locked like that (he locks his fists together). For three years, every year we meet and we play.
S.Z.: So maybe there is an Americana/Ghanaian album in your future?
O.A.: Well actually, yes. Mike and I are going to work on an album which addresses our backgrounds then meet in the middle to see the differences, but mostly the similarities. This is an album that we just started talking about that we are going to make. There are all of these ideas that really blend effortlessly.
S.Z.: “Messenger” is your third album. How does this work represent your evolution as a person, an artist and a performer?
O.A.: “The Traditionalist,” my first album, was raw, untouched feelings of Ghanaian traditional music. Nothing else. No tricks, nothing. Besides, I don’t like tricks on an album. I like the voice to sound like me. But “The Traditionalist” preserves my past. The second album was the beginning of thinking about the African Diaspora. You can hear me trying to blend different vocal ideas and cultures. It is a little bit adventurous. This album, “Messenger,” is where I am now. I have evolved. You can think about the past and where you are from, but all you have is now.
S.Z.: What message do you hope to bring to your audiences?
O.A.: I think what I bring, and what American audiences are very hungry for, are fusions. I have been working on a song called African Cowboy. I played it a few weeks ago when I was in Alaska. Mike and Raymond were there too, and I said I want to play this song. We didn’t practice, we just played it right there. The audience heard it, and when they came to buy CDs they were asking, “Do you have that song, African Cowboy? I had to tell them, no. I think the American audience are really hungry for something like that, to hear the blending of musical genres. And maybe they think that there must have been a time when we were all one people. To really reconnect it back. That is really what I hope that when people come to my show or when they hear my music, they hear that. When I go to play in other communities, I always find someone to collaborate with. I am not only showing what I am doing, but I am showing that I want to know about you, too. Through music we can see our similarities.
S.Z.: When was the last time you were in Ghana?
O.A.: Three years ago. I am going back in December.
S.Z.: Do the people in your town notice any kind of change in the climate or the weather?
O.A.: There is no big talk. But I can tell you this: Global warming is happening. I remember where I used to play on the coast when I was growing up. The ocean is coming. It has traveled inland quite a bit. It has taken some land. But people are not really thinking of it that way. If you are not a scientist and you are a fisherman, you will notice those little subtle changes, but you are not going to know why. They don’t think about it as global warming, but I can see it happening.
I remember when I was growing up, there were so many coconut trees, and I remembered places that we would take naps. I remember the fisherman had to pull their canoes so far up from the water. And it’s not that far up anymore. The ocean is traveling. You don’t see it if you are living there. But if you go back, you will notice many changes.
S.Z.: What words would you share with the youth of today in regard to the future of our world, be they American or Ghanaian?
O.A.: I say cultural preservation. I feel like there are a lot of Ghanaian musicians who think they need to advance so much. The only people who are preserving the culture of Ghana are the people who are playing the traditional drum. They will be the greatest ambassadors, not the people who went to the business schools, not the people who became lawyers, not the people who become even president. If we give them the platform, it is the people who learn about their culture who will be the ambassadors.
Photo by Kristina Wright

domain: sociology


text:
There are one large image and several thumbnail. One of the tittle is Childrens coloring pages | coloring pages for kids. Horse coloring pages, sheets and pictures. Cat coloring pages - free and printable. Coloring pages: animal coloring sheets for kidsfun coloring | fun. Kids coloring sheets printable iron man coloring pages for kids.
Large picture on this page is categorize in childrens coloring sheets.


text:
She said she’s sorry — but she’s staying put. Orange County Republican activist Marilyn Davenport apologized on Wednesday for forwarding an email that featured President Obama’s face superimposed on that of a chimpanzee with the caption: “Now you know why — No birth certificate!”
At a news conference in front of her Fullerton home, Davenport conceded that her action was “unwise.”
“I assume I offended the black people,” she said. “And, uh, having friends that are black, I never intended that. Not at all.”
Davenport said she considered the email “political satire.” She’s refused to resign her seat on the Orange County Republican Central Committee.
“I am getting comments from my constituents asking me ‘please do not. Do not resign.’ And out of respect for my constituents, I will continue to remain in office,” Davenport said.
Orange County GOP Chairman Scott Baugh has called on Davenport to resign.

domain: news


The Climate Change Act has formalised the UK’s approach to tackling climate change – both on mitigation (reducing emissions) and adaptation (increasing resilience to climate change). It provides a clear direction of travel, while allowing for flexibility and innovation.
- The Act was based on and has helped to maintain a remarkable cross-party consensus.
- The Act also created the independent Climate Change Committee. The CCC has helped to ensure that the UK’s overall direction of travel on climate change has remained focused on achieving the long-term 2050 target, and kept this aim separate from political fluctuations. As such, much of the Committee’s advice has been instrumental in the UK’s success so far.
- The Act puts in place a rolling cycle of statutory national risk assessments and a resulting Adaptation Programme that must address the risks. Few other countries have a statutory adaptation process of this kind.
- The Act has cemented the UK’s position as an international leader in tackling climate change. Other countries have also introduced their own legislation, and many have based it on the UK’s Climate Change Act (e.g. Sweden, New Zealand).
- Since 2008, six carbon budgets have been approved by Parliament. These budgets create a smooth and practical pathway towards meeting the UK’s 2050 greenhouse gas emissions reduction target of at least 100% compared to 1990 levels.
- UK emissions have continued to fall since the Climate Change Act was passed in 2008.


Universal, high-performance aluminium oxide abrasive on a flexible cotton cloth backing for applications requiring low to medium contact pressure. Characterised by its long lifetime and good adaptability. Especially suitable for working on contours, fittings or edge finishing.
- Long service life
- Universally applicable
- High performance abrasive
- Good adaptation to the workpiece


text:
Download Flying Spider Firehero Robot mod apk v2.2 for Android
|Name||Flying Spider Firehero Robot|
|Download||Download Mod Apk|
Flying Spider Firehero Robot
Flying Spider Firehero Robot Game Introduction ：
Let’s start your superhero rescue mission with flying speed hero robot in fire hero robot games to save gangster crime city. Tackle all fun zones in spider rescue missions of robot fire hero Games in a unique approach by joining the flying fire robot hero missions and work in gangster crime city with flying fire superhero that can help people and rescue animals in tough attacking in flying spider firehero robot games. Spider rope firehero robot rescue mission operation is now done by flying fire superhero robot games with fully light flying spier speed hero transform flying ambulance to save the city.
In flying spider rope hero gangster crime city games you have to show your superhero flying skills of real robot superhero games. Enjoy flying police robot rope hero in the gangster crime city and get ready for a super hero rescue mission. Become a futuristic robot superhero for a great climbing experience with a flying rope fire hero in a flying police game. Take advantage of light speed robot hero rescue powers in flying superhero rescue mission as a flying light speed hero robot and fulfill all the police speed fire hero rescue mission needs by moving in a flying robot speed hero games of fire superhero flame battle games.
Fly as a super robot fire speed hero to help and assist the flying superhero rescue in flying fire hero robot games. Get ready for fire rope hero rescue as a super speed robot hero in a police robot firehero gangster game. Spider fire superhero fighters are ready in a powerful superhero rescue mission in a cop robot speed hero game. Reveal speed robot fire hero adventures in police robot flying spider superhero game and have fun with an amazing robot fire hero. Super robot rescue mission is going to take part in city rescue missions of police game.
Become master of spider hero game as a city rescue mission to save the city from crime gangster by getting a feeling like Spider hero robot game and Police robot game. Enjoy Flying superhero games to enjoy the interesting story of Flying superhero robot game and City rescue mission game. Flying robot crime city rescue game is designed for all those who love comics and superhero games. If you want to live a life of a fire flying superhero and you have the ability to rescue the citizens in a grand city from criminal gangsters then join this fire spider flying hero fighting simulator where you will fight against the ultimate robot city crime gangster mafia.
Try more exciting than a flying rescue robot and get rescued from superhero robot simulator powers in this grand gangsters crime city rescue game. You have no limit of flying superhero action in a city ambulance simulator game and you can cover all your superhero rescue missions with all your superhero flying powers. Flying Speed Hero Robot is your role to start superhero rescue mission 3d in a flying robot game of flying superhero games. Flying robot rescue games are fully equipped with flying superhero robot rescue mission where you have to save the lives of people and animals with your superhero rescue powers.
Flying Superhero Robot Superhero Rescue Mission features:
• Flying Superhero Rescue Games Mission
• Flying robot hero rescue mission games survival.
• Enjoy game plans of flying hero games.
• Full fledged role of Light superhero robot rescue
• Flying superhero rescue simulator of black spider superhero flying games.
So what are you waiting for ?? Get into the world of flying fire superhero battle games who have the ability to fight crime in this gangster crime simulator superhero city crime games. Start your career as a police fire hero robot doing a wonderful job to save people in flying superhero games to rescue them to the hospitals. You must take all the responsibilities of gangster crime city on your shoulders as nobody is ready to protect the lives other than flying fire hero robot.


text:
| May 11, 2012
| 9:06 AM
How to Grow a Band
May 11&12, and 18 & 19, Real Art Ways, 56 Arbor St., Hartford, (860) 232-1006, realartways.org
For anyone looking to gain practical music-business insights from watching How to Grow a Band — a new documentary about the Punch...
| Sep 13, 2012
| 5:03 AM
The 2012 Kennedy Center Honors recipients were announced yesterday and they include Led Zeppelin, Chicago blues legend Buddy Guy, late-night talk show staple David Letterman, Oscar-winning actor Dustin Hoffman and ballerina Natalia Makarova. Led...
| Mar 11, 2012
| 7:34 PM
Sitting between fifth-year seniors Mike Scott and Sammy Zeglinski, Virginia coach Tony Bennett wanted to will his team's name to appear on the screen Sunday night as he watched the NCAA men's basketball tournament selection show with his players and...
| Dec 1, 2012
| 11:33 AM
Looking for an opportunity to hear Led Zeppelin deflect questions -- once again -- about a reunion?
Be sure to catch "The Late Show with David Letterman" on Monday night, when Robert Plant, Jimmy Page and John Paul Jones will sit down for a joint...
| Dec 3, 2012
| 4:56 AM
In the world of scoring television late show guests, getting the three surviving members of Led Zeppelin to sit down together for an ultra-rare joint interview could be the equivalent of hitting a grand slam in the bottom of the ninth to with the World...
| Dec 3, 2012
| 8:00 AM
WASHINGTON -- An array of talents was on display Sunday at the Kennedy Center Honors gala where President Barack Obama toasted the lifetime achievements of an iconic ballerina, a famed comedian, a timeless actor and two chart-topping musical acts.
| Dec 4, 2012
| 5:14 AM
Robert Plant, Jimmy Page and John Paul Jones of Led Zeppelin and CBS’ Late Show host David Letterman swapped one-liners last night during the band’s very rare joint appearance on late-night television. Early in the interview, Letterman asked...
| Nov 12, 2012
| 6:37 AM
A concert film that captured Led Zeppelin's 2007 reunion concert in London is coming back to Hampton for one showing. If you missed the movie "Celebration Day" when it played here last month, here's your second chance.
The movie will play 7:30 p.m....
| Nov 13, 2012
| 10:35 AM
NBC's futuristic sci-fi series "Revolution" is turning to classic rock heroes Led Zeppelin to score its Thanksgiving-week episode. Two of the band's songs, "Kashmir" and "Since I've Been Loving You," are set to appear Monday on the J.J. Abrams-produced...
| Nov 15, 2012
| 7:36 AM
Led Zeppelin have unleashed their performance of Black Dog from their Celebration Day movie, shot at their 2007 reunion concert. View it here. Guitarist Jimmy Page has recorded an interview with the BBC’s Jools Holland, in which he admits he’d...
| Jun 12, 2011
| 9:34 PM
Ravinia season is in full swing, which means folks across Chicagoland are flocking to Highland Park to enjoy the sounds of summer at the famous …...

domain: hobby


text:
Welcome to Fistful of Features, a celebration of film preservation through physical media and the discussion of cinematic treasures to maintain their relevance in the cultural lexicon. Today we’ll be discussing the director’s cut of Christophe Gans’s fantastical hodgepodge of horrific folklore, alternate history, erotic fetishism, and martial arts, the ambitiously entertaining Brotherhood of the Wolf, now available in a collector’s edition Blu-ray courtesy of Scream Factory.
“Ghost or not, I’ll split you in two.” – Jean-François de Morangias
Christophe Gans’s (Silent Hill) approach to telling the legend of The Beast of Gévaudan is like having a teacher explain folklore to a classroom completely detached from the subject. Theoretical scenario. Teacher asks “Hey, everybody. Would you like to hear about a massacre in the Kingdom of France that was widely believed to be the result of a monstrous hybrid of a hyena or ravenous wolf?” Mildly amused class replies “I guess.” Teacher retorts “But wait, I’m not finished. This is a swashbuckling tale involving incestuous secret societies, a one-armed aristocrat with silver bullet fetishes, a Mohican warrior who could go toe to toe with Bruce Lee, an abundance of brothels and political double crossing that would put Game of Thrones to shame, and a mythical creature whose blood-thirst has a preference for women and newborn children.”
You could only imagine the wide-eyed students eating out of the enthusiastic storyteller’s palm.
Cinematographer Dan Lausten (Crimson Peak) sets the mood with fog against the lavish gothic backdrop that wouldn’t be out of place in a Tim Burton production. Grégoire de Fronsac (Samuel Le Bihan), a loyal knight to King Louis XV of France, and his Native American companion Mani (Mark Dacascos) arrive in Gavaudan to hunt and capture the alleged beast responsible for a string of serial killings that would put Jack the Ripper to shame. The more they become involved in the town, the more suspicious these crimes appear to be, and when Fronsac finds himself in an intense romantic triangle with Marianne (Emilie Dequenne) much to the chagrin of her jealous brother Jean-François de Morangias (Vincent Cassel) and Sylvia (Monica Bellucci), he finds that the rabbit hole of truth is far deeper than he would ever have imagined.
The beast in question, at times, looks wondrously impressive thanks to the fine animatronic puppetry work courtesy of Jim Henson’s Creature Shop, though the scenes that required the aid of CGI haven’t aged as gracefully. The fight choreography by action coordinator Manu Lanzi (The Transporter) also hold up magnificently well. There’s a scene where Mani is tracking the creature back into an ambush and is surrounded by conspirators looking to tear him apart. Mark Dacascos contains so much finesse and conviction with disposing of his opponents that it’s a no brainer to cast him as the baddie in recent fare like John Wick: Chapter 3 – Parabellum. Brotherhood of the Wolf plays fast and loose with folklore and the French Revolution. It’s like Drunk History leaning more on tragedy than laughs with a dash of From Hell and Sleepy Hollow for good measure.
The extras included on Scream Factory’s two disc collection are ported from previous releases, but are quite extensive if you haven’t seen them. For those looking for a fun genre mashup that delivers some thrilling action sequences and haunting atmosphere you really can’t go wrong with adding this to your Scream Factory collection.
The Brotherhood of the Wolf Special Features:
Disc One: Feature Film
- Unrated Director’s Cut Of The Film
Disc Two: Bonus Features
- The Guts Of The Beast – A Look At The Creation Of The Film From The Fight Scenes To The Digital Effects
- The Making Of BROTHERHOOD OF THE WOLF – A Look Behind-The-Scenes
- The Legend – A Look At The Historical Facts Behind The Legend Of The Gévaudan Beast
- Deleted Scenes With Introduction By Director Christophe Gans
- Theatrical Trailers
Available on Blu-ray from Shout! Factory July 27th, 2021.

domain: entertainment


text:
Our heroes are dressed in homemade uniforms and armed with prop phasers but soon find themselves defending their hotel and convention center against hordes of flesh-eating undead. Suddenly, all of their useless knowledge about particle physics and old Star Trek episodes has genuine real-world applications! And while hotel employees and regular civilians are dying left and right, our Trekkies summon strength and courage by emulating their favorite starship-voyaging characters.
Packed with hundreds of gags referencing Star Trek, comic books, and fan conventions, Night of the Living Trekkies reads like the strange lovechild of Galaxy Quest and Dawn of the Dead. Journey to the final frontier of zombie science-fiction mash-ups!
This is an original work of parody and is not officially sponsored by, affiliated with, or endorsed by the owners of the Star Trek brand.
Regular price: £23.79
Buy Now with 1 Credit
Buy Now for £23.79
Customer ReviewsMost Helpful
By P. J. Williams on 02-04-11
Admit it - you're a Trekkie/Geek/Nerd/Gamer/Zombie
- or you wouldn't even be looking at this book!
Not going to try to pr?cis the book suffice to say its fun, plain and simple.
I didn't consider myself a Trekkie etc but the number of references that I picked up on leaves me to believe that a 'REAL' Trekkie would find so many more, well worth taking a on long road trip especially with like minded friends!
1 of 1 people found this review helpful
By Mark on 28-07-14
Would you recommend this audiobook to a friend? If so, why?
Great humour, interesting concept, surprising heroes.
What other book might you compare Night of the Living Trekkies to, and why?
Nothing like it out there!
What does Zach McLarty bring to the story that you wouldn’t experience if you had only read the book?
Zach McLarty brings humour to the story but takes it seriously. The author has his tongue in his cheek if Zach had too it would have over done it.
If you made a film of this book, what would be the tag line be?
There are so many tag lines you could link to from Star Trek whatever I suggest someone else would improve on it
Any additional comments?
It's just a major, fun, surprise!
Customer ReviewsMost Helpful
By Brian Moakley on 11-09-10
Truth be told, most zombie fiction is pretty bad. Whether it be the poor writing or bland characters put into cliche scenarios, I tend to put down most of these books rather than finish them. Thankfully, this book avoids a lot of the pitfalls and tells a funny albeit dramatic story about Star Trek fans trying to survive a zombie apocalypse. It's a fun read for sure, and if you're a Trekkie, you'll love all the Star Trek references scattered throughout the pages. Each chapter is named after an episode which works most of the time.
The wonderful thing about this book is that keeps its eyes always focused on the story. The characters feel real and their encounters can be gripping and sometimes tragic. The concept, while funny, is kept in check by the author's attention to plot and character.
Honestly, this could have been a disaster with lesser skilled writers, but instead, it was a refreshing read that I highly recommend.
9 of 9 people found this review helpful
By Ray Price on 21-09-10
Even several glaring factual errors (both in Star Trek Mythos and in Science) were not able to derail this fun, fun, listen. Even the chapter titles would put a smile on my face. If you enjoyed the movie Free Enterprise, you'll enjoy this book
6 of 6 people found this review helpful